August 8, 2020 /

Emerging Strategies in Duchenne


The PPMD team is joined by leading Duchenne researchers to discuss exciting areas of research in development that hold promise for Duchenne, such as gene editing and non-viral delivery.

Panelists:
Kevin Flanigan, MD, Nationwide Children’s Hospital
Melissa Spencer, PhD, UCLA

Join Our Mailing List